MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
about
PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.MiR-103 alleviates autophagy and apoptosis by regulating SOX2 in LPS-injured PC12 cells and SCI rats.MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.
P2860
MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@ast
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@en
type
label
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@ast
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@en
prefLabel
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@ast
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@en
P2093
P2860
P356
P1433
P1476
MAP4K4 is a novel MAPK/ERK pat ...... ng adenocarcinoma maintenance.
@en
P2093
Chenxi Gao
Dennis Han Zhang
Guangming Chen
Guoxiang Liu
Laura P Stabile
Shih-Fan Kuan
P2860
P304
P356
10.1002/1878-0261.12055
P577
2017-03-17T00:00:00Z